[go: up one dir, main page]

AU2003281179A1 - Remedies for pigmentation - Google Patents

Remedies for pigmentation

Info

Publication number
AU2003281179A1
AU2003281179A1 AU2003281179A AU2003281179A AU2003281179A1 AU 2003281179 A1 AU2003281179 A1 AU 2003281179A1 AU 2003281179 A AU2003281179 A AU 2003281179A AU 2003281179 A AU2003281179 A AU 2003281179A AU 2003281179 A1 AU2003281179 A1 AU 2003281179A1
Authority
AU
Australia
Prior art keywords
remedies
pigmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003281179A
Inventor
Hideyasu Takada
Tsukasa Takemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003281179A1 publication Critical patent/AU2003281179A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
AU2003281179A 2002-07-12 2003-07-10 Remedies for pigmentation Abandoned AU2003281179A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002204431 2002-07-12
JP2002-204431 2002-07-12
JP2003189581A JP4786127B2 (en) 2002-07-12 2003-07-01 Antipigmentation treatment
JP2003-189581 2003-07-01
PCT/JP2003/008764 WO2004006908A1 (en) 2002-07-12 2003-07-10 Remedies for pigmentation

Publications (1)

Publication Number Publication Date
AU2003281179A1 true AU2003281179A1 (en) 2004-02-02

Family

ID=30117451

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003281179A Abandoned AU2003281179A1 (en) 2002-07-12 2003-07-10 Remedies for pigmentation

Country Status (3)

Country Link
JP (1) JP4786127B2 (en)
AU (1) AU2003281179A1 (en)
WO (1) WO2004006908A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0317696B8 (en) * 2002-12-27 2021-05-25 Daiichi Seiyaku Co whitening composition
US20050048012A1 (en) * 2003-08-26 2005-03-03 Roland Jermann Use of biotin or a biotin derivative for skin lightening purposes and for the treatment of senile lentigines
JP2005314403A (en) * 2004-03-31 2005-11-10 Dai Ichi Seiyaku Co Ltd Novel bleach composition
JPWO2006003965A1 (en) * 2004-06-30 2008-04-17 第一三共ヘルスケア株式会社 Whitening composition
JP2007063223A (en) * 2005-09-01 2007-03-15 Kobayashi Pharmaceut Co Ltd Oral composition and food for prevention or treatment of spot or freckle
JP2007063224A (en) * 2005-09-01 2007-03-15 Kobayashi Pharmaceut Co Ltd Tyrosinase activity inhibitor
CN102105143B (en) 2008-08-06 2013-03-20 第一三共健康事业株式会社 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid
CN102137664B (en) * 2008-09-05 2014-08-06 第一三共健康事业株式会社 Solid pharmaceutical preparations with active ingredients separated by boundaries
JP2011219402A (en) * 2010-04-08 2011-11-04 Pola Chemical Industries Inc Pomc production inhibitor
JP6172740B2 (en) * 2013-04-30 2017-08-02 株式会社シャネル化粧品技術開発研究所 Method for screening candidate compounds for modulating melanogenesis or pigmentation
JP2023056255A (en) * 2021-10-07 2023-04-19 エスエス製薬株式会社 Pigmented spot formation inhibitor, increased melanosome phagocytosis inhibitor, and epidermal differentiation potency improver

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56154409A (en) * 1980-04-30 1981-11-30 Pola Chem Ind Inc Skin-bleaching cosmetic
JPH04243825A (en) * 1991-01-25 1992-08-31 Ss Pharmaceut Co Ltd Remedy for pigmentation
JPH0680564A (en) * 1992-09-03 1994-03-22 Meiji Seika Kaisha Ltd Anti-pigmentation agent
JPH1192326A (en) * 1997-09-22 1999-04-06 Shiseido Co Ltd Skin preparation for external use
JP4115656B2 (en) * 2000-10-11 2008-07-09 株式会社坂本バイオ Melanin production inhibitor and whitening agent comprising ergosterol derivative
JP2002193796A (en) * 2000-12-27 2002-07-10 Ajinomoto Co Inc Inhibitor to activation of inflammatory factor, usage thereof and new polysulfide derivative usable for the same

Also Published As

Publication number Publication date
JP4786127B2 (en) 2011-10-05
JP2004091473A (en) 2004-03-25
WO2004006908A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
EP2295053B8 (en) Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2002952554A0 (en) Monitower
AU2003227711A1 (en) 5-ethylimidarotriazones
AU2003283626A1 (en) Catheter
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003272902A1 (en) Remedies
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003281179A1 (en) Remedies for pigmentation
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003221050A1 (en) Remedy for hypermyotonia
AU2003228198A1 (en) Av-fistula bandage
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003272901A1 (en) Remedies
AU2003244140A1 (en) Catheter
AU2003264443A1 (en) Preparation for external use
AU2003207181A1 (en) Microorganism-trapping agent
AU2003238180A1 (en) 2-naphtamide derivatives
AU2003273398A1 (en) Aroyl-piperidine derivatives
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003288012A1 (en) Isothiazolyl-benzoxazine derivatives
AU2003227916A1 (en) Kiteboard
AU2003243397A1 (en) Homo-camptothecin derivatives
AU2003236239A1 (en) Remedies

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase